Certified ISO 9001 : 2015 by
Sakar
Healthcare Limited
Corporate Office:
406, Silver Oaks Comm. Complex.
Opp. Arun Society, Paldi,
02-02-2023
Ahmedabad-380 007. Gujarat, India.
Phone : 079-26584655
fax:
079-26588054
The Manager,
Listing Compliance Department,
National Stock Exchange of India Ltd,
Exchange Plaza, Bandra Kurla Complex,
Bandra (East), Mumbai - 400051
CIN No. : L2423 1GJ2004PLC043861
E-mail
Web
: info@sakarhealthcare.com
: www.sakarhealthcare.com
Symbol: SAKAR
Subject: Meeting with strategic global team of Ferring Pharmaceutical
(pharma giant from Switzerland)
for their oncology product development and manufacturing (CDMO) on 3rd/4th Feb-2023
Ref.: Announcement
under Regulation 30 (LODR)
Dear Sir/Madam,
It is our pleasure to inform that Ferring global leadership team from Zurich- Switzerland and Mumbai &
Hyderabad- India has scheduled to meet Sakar Healthcare team at Ahmedabad, Gujarat, India for signing off
their contract on 3rd and 4th February 2023. The Ferring global team will include key members of R&D and
product Life Cycle Management from International Centre and India. Ferring Pharmaceutical is a Switzerland
headquartered, research-driven speciality pharmaceutical group with world-wide presence in key therapeutic
categories having differentiated novel drug delivery.
Both Ferring and Sakar leadership team have decided to join hands for signing contract for development and
supply of oncology products. Ferring core team has evaluated the scope for best in class development of their
technologically advanced products and will share their expectations during their tour at the oncology
manufacturing site at Sakar, meeting key stake-holders. This is indicative of the fact that the developed hi-tech
products can reach across countries of Ferring's operation in near future.
It is worth mentioning that Ferring Pharma will be next multinational after Zydus Lifesciences (who has signed
an agreement with technology transfer of their range of oncology products early October 2022), collaborating
with Sakar to leverage each other's potential to develop and manufacture (CDMO) anti-cancer products at
Sakar's research-driven, API-integrated, oncology formulation and lipoid complex molecule manufacturing site.
The discussion will be based on publicly available information. No unpublished price-sensitive information will
be shared/discussed in the Meeting
This is for your information, records and meeting the disclosure requirements under the SEBI (Listing
Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time.
Thanking you,
Yours faithfully,
for SAKAR HEALTHCARE
BHARATKUMAR
SUKHLAL SONI
LIMITED
Digitally signed by BHARATKUMAR SUKHLAL SONI
DN: c=IN, postalCode=383110, st=GUJARAT, l=SABARKANTHA, o=Personal,
serialNumber=1ef7c1b696310b37cb077a5f28af2fae1b1f4845ca91b237cb894d3e54
3896f5, pseudonym=831c580462b24e56afe02b4130943821,
2.5.4.20=96fb7f4339cbe1eb8ca04cd9c7eb0172baf640fabdd5e89840d8ac4c6794e0
78, email=CS.BHARATSONI@GMAIL.COM, cn=BHARATKUMAR SUKHLAL SONI
Date: 2023.02.02 12:47:16 +05'30'
BHARATSONI
COMPANY SECRETARY
COMPLIANCE OFFICER
&
Regd. Office / Works: Block No. 10-13, Sarkhej-Bavla Road, Village Changodar, Dist. Ahmedabad - 382 213. India.
Phone: 02717 250477
Fax: 02717 251621